By Karunjit Singh ( December 16, 2025, 4:48 PM EST) -- The Federal Court of Appeal has upheld a trademark injunction against Samsung and Biogen over their BYOOVIZ biosimilar, ruling that patients are relevant consumers in assessing confusion with Novartis’s trademark in BEOVU, a drug used to treat neovascular age-related macular degeneration (wet AMD)....